EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease

Yufei Shen, Zhuoying Zhu, Yanping Wang, Shuxia Qian, Congying Xu, Baorong Zhang

Experimental Brain Research · 2024

DOI: 10.1007/s00221-023-06709-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Brain Research, 2024. Verfasst von Yufei Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Zhejiang University, Hangzhou, 310009, China. Hauptthemen laut MEDLINE: Neuroblastoma, Parkinson Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is one of the most common and complex Neurodegeneration, with an inherited metabolic disorder. Fibroblast growth factor 21 (FGF21), an endocrine hormone that belongs to the fibroblast growth factor superfamily, plays an extensive role in metabolic regulation. However, our understandings of the specific function and mechanisms of FGF21 on PD are still quite limited. Here, we aimed to elucidate the actions and the underlying mechanisms of FGF21 on dopaminergic neurodegeneration using cellular models of parkinsonism. To investigate the effects of FGF21 on dopaminergic neurodegeneration in vitro, proteasome impairment models of PD were utilized. Human dopaminergic neuroblastoma SH-SY5Y cells were treated with the proteasome inhibitor lactacystin (5 μmol/L) for 12 h, then with 50 ng/ml FGF-21 with or without 5 mmol/L of 3-methyladenine.The cells were dissected to assess alterations in autophagy using immunofluorescence, immunoblotting and electron microscopy assays. Our data indicate that FGF21 prevents dopaminergic neuron loss and shows beneficial effects against proteasome impairment induced PD syndrome, indicating it might be a potent candidate for developing novel drugs to deal with PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaParkinson DiseaseHumansAutophagyDopamineDopaminergic NeuronsFibroblast Growth FactorsProteasome Endopeptidase Complex

Stichwörter der Autor:innen

AutophagyFibroblast growth factor 21NeurodegenerationParkinson’s diseaseProteasomeUbiquitin–proteasome system

Substanzen

Dopaminefibroblast growth factor 21Fibroblast Growth FactorsProteasome Endopeptidase ComplexFGF21 protein, human

Autor:innen und Institutionen

  • College of Medicine, Zhejiang University, Hangzhou, 310009, China.
  • Department of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314001, China.
  • Department of Neurology, College of Medicine, Second Affiliated Hospital, Zhejiang University, Hangzhou, 310009, China. brzhang@zju.edu.cn.

Zitieren

APA

Shen, Y., Zhu, Z., Wang, Y., Qian, S., Xu, C., & Zhang, B. (2024). Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease. Experimental Brain Research. https://doi.org/10.1007/s00221-023-06709-3

Vancouver

Shen Y, Zhu Z, Wang Y, Qian S, Xu C, Zhang B. Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease. Experimental Brain Research. 2024. doi:10.1007/s00221-023-06709-3

BibTeX
@article{Shen2024,
  author = {Shen, Yufei and Zhu, Zhuoying and Wang, Yanping and Qian, Shuxia and Xu, Congying and Zhang, Baorong},
  title = {Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease},
  journal = {Experimental Brain Research},
  year = {2024},
  doi = {10.1007/s00221-023-06709-3}
}
Kostenlos starten →